COVID-19 PANDEMIC UPDATES
|
Learn more

Should patients receive HLA-selected platelets?

What is this research about?

Hypoproliferative thrombocytopenia (HT) occurs when production of blood platelets by the bone marrow is reduced. HT may occur in patients with leukemia, aplastic anemia or in cancer patients after chemotherapy. In patients with HT, platelets are transfused to increase the platelet count to prevent excessive bleeding.

Published on